Another hint that B-OM is working: “It has be
Post# of 72440
Posted On: 10/30/2015 1:20:04 PM
Another hint that B-OM is working:
“It has been decades since a new class of antibiotics has made it to phase 3,” said Dr. Daniel Jorgensen, Cellceutix’s Chief Medical Officer. “Brilacidin is unique in its structure and function. As an antibiotic, it is can kill bacteria that are resistant to other antibiotics, such as methicillin-resistant Staphylococcus aureus (MRSA), a major cause of ABSSSI. And we believe that resistance to brilacidin is unlikely to occur. As for brilacidin’s immunomodulatory activity, we are just scratching the surface.”
“It has been decades since a new class of antibiotics has made it to phase 3,” said Dr. Daniel Jorgensen, Cellceutix’s Chief Medical Officer. “Brilacidin is unique in its structure and function. As an antibiotic, it is can kill bacteria that are resistant to other antibiotics, such as methicillin-resistant Staphylococcus aureus (MRSA), a major cause of ABSSSI. And we believe that resistance to brilacidin is unlikely to occur. As for brilacidin’s immunomodulatory activity, we are just scratching the surface.”
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼